Frequently Asked Questions
The market is segmented based on Middle East and Africa Vaccine Administration Devices Market, By Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Autoinjector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, B.C.G. Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
.
The Middle East And Africa Vaccine Administration Devices Market size was valued at USD 100.45 USD Million in 2022.
The Middle East And Africa Vaccine Administration Devices Market is projected to grow at a CAGR of 4.4% during the forecast period of 2023 to 2030.
The market report covers data from the Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (M.E.A.) as a part of Middle East and Africa (M.E.A.).
